Delivery Method: VIA EMAIL WITH READ RECEIPT Reference #: 320-25-67 Product: Drugs Recipient: Recipient Name Mr. Arvind Nanda Recipient Title Joint Managing Director Mentha & Allied Products Private Ltd. 16th Km Rampur-Swar Road Rampur 244901 Uttar …
Delivery Method: VIA UPS Reference #: 320-25-57 Product: Drugs Recipient: Recipient Name Mr. Kee Pee Ho Recipient Title Managing Director BioAsia Worldwide Sdn Bhd H-G-01 & H-01-01 Block H – Sekitar 26 Persiaran Hulu Selangor, HICOM Industrial Estate, …
Delivery Method: VIA EMAIL WITH READ RECEIPT Reference #: 320-25-70 Product: Drugs Recipient: Recipient Name Mr. Bernard Fraisse Recipient Title President & CEO Excelvision Fareva 32 Pl. de la Gare, 1616 Gare Luxembourg France Issuing Office: Center …
Delivery Method: VIA Electronic Mail Reference #: 320-25-60 Product: Drugs Recipient: Recipient Name Mr. Zheng Liang Recipient Title General Manager Taizhou Jingshang Cosmetics Technology Co., Ltd. 888 South Huanzhen Road Hengie Town Luqiao Qu Taizhou Shi …
FDA News Release Department marks significant progress on Operation Stork Speed For Immediate Release: May 13, 2025 The U.S. Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA) today announced the next steps in …
For Immediate Release: May 13, 2025 The U.S. Department of Health and Human Services (HHS) and the U.S. Food and Drug Administration (FDA) today announced the launch of a public Request for Information (RFI) to identify and eliminate outdated or …
[Posted 05/12/2025] AUDIENCE: Patient, Health Care Professional, Pharmacy ISSUE: The FDA and the CDC are recommending a pause in the use of Ixchiq (Chikungunya Vaccine, Live) in individuals 60 years of age and older while the Agencies investigate …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
COMPANY ANNOUNCEMENT When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. Read Announcement View Product Photos …
For Immediate Release: December 05, 2025 The U.S. Food and Drug Administration today announced the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot, a voluntary pilot designed to promote access to certain digital …
Fresh & Ready Foods Breakfast Bistro Box 4oz 1-FRBIST001 PLASTIC CONTAINER 05/09/2025 - 05/12/2025 Fresh & Ready Foods Antipasto Bistro Box 4oz 1-FRBIST002 PLASTIC CONTAINER 05/09/2025 - 05/12/2025 Fresh & Ready Foods Artisan Cheese Bistro Box …
For Immediate Release: November 05, 2025 The U.S. Food and Drug Administration issued 18 warning letters to owners of websites illegally marketing unapproved and misbranded botulinum toxin products, commonly called Botox. The agency is aware of adverse …
Recipient: Derma Solution United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 Derma Solution: This is to advise you that the United States (U.S.) Food and Drug …
Recipient: Glowface United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 Glowface: This is to advise you that the United States (U.S.) Food and Drug …
Recipient: Meamo South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 Meamo: This is to advise you that the United States (U.S.) Food and Drug Administration (FDA …
Recipient: MJS Medicals South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 MJS Medicals: This is to advise you that the United States (U.S.) Food and Drug …
Recipient: COSMO KOREA South Korea Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 COSMO KOREA: This is to advise you that the United States (U.S.) Food and Drug …
Recipient: Glam Derma Netherlands Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 Glam Derma: This is to advise you that the United States (U.S.) Food and Drug …
Recipient: CelestaPro United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 CelestaPro: This is to advise you that the United States (U.S.) Food and Drug …
Recipient: Korean Aesthetic dba Korean Fillers United States Issuing Office: Center for Drug Evaluation and Research (CDER) United States Secondary Issuing Offices WARNING LETTER November 3, 2025 Korean Aesthetic dba Korean Fillers: This is to advise you …
05 days 01:49:16
